Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

116 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Graphene oxide and oxidized carbon nanodiscs as biomedical scaffolds for the targeted delivery of quercetin to cancer cells.
Zygouri P, Tsiodoulos G, Angelidou M, Papanikolaou E, Athinodorou AM, Simos YV, Spyrou K, Subrati M, Kouloumpis A, Kaloudi AS, Asimakopoulos G, Tsamis K, Peschos D, Vezyraki P, Ragos V, Gournis DP. Zygouri P, et al. Among authors: ragos v. Nanoscale Adv. 2024 Apr 17;6(11):2860-2874. doi: 10.1039/d3na00966a. eCollection 2024 May 29. Nanoscale Adv. 2024. PMID: 38817436 Free PMC article.
PTEN Deregulation Mechanisms in Salivary Gland Carcinomas.
Papanikolaou V, Chrysovergis A, Adamopoulou M, Spyropoulou D, Roukas D, Papanastasiou G, Mastronikoli S, Papouliakos S, Manaios L, Tsiambas E, Pantos P, Ragos V, Fotiades P, Peschos D, Mastronikolis N, Kyrodimos E. Papanikolaou V, et al. Among authors: ragos v. Cancer Diagn Progn. 2024 Jan 3;4(1):25-29. doi: 10.21873/cdp.10280. eCollection 2024 Jan-Feb. Cancer Diagn Progn. 2024. PMID: 38173659 Free PMC article. Review.
Impact of Amplified Oncogenes on Salivary Gland Carcinomas.
Papanikolaou V, Chrysovergis A, Asimakopoulos AD, Spyropoulou D, Ragos V, Papanastasiou G, Papouliakos S, Mastronikoli S, Roukas D, Tsiambas E, Pantos P, Peschos D, Mastronikolis N, Manaios L, Fotiades P, Vylliotis A, Kyrodimos E. Papanikolaou V, et al. Among authors: ragos v. Cancer Diagn Progn. 2023 Sep 3;3(5):528-532. doi: 10.21873/cdp.10250. eCollection 2023 Sep-Oct. Cancer Diagn Progn. 2023. PMID: 37671310 Free PMC article. Review.
Mutational Signatures in Salivary Gland Carcinomas.
Chrysovergis A, Papanikolaou V, Spyropoulou D, Roukas D, Asimakopoulos AD, Papanastasiou G, Mastronikoli S, Falidas E, Papouliakos S, Tsiambas E, Pantos P, Ragos V, Peschos D, Mastronikolis N, Kyrodimos E. Chrysovergis A, et al. Among authors: ragos v. Cancer Diagn Progn. 2023 Jul 3;3(4):411-415. doi: 10.21873/cdp.10233. eCollection 2023 Jul-Aug. Cancer Diagn Progn. 2023. PMID: 37405215 Free PMC article. Review.
Brain Perfusion Changes in a Patient with Facial Trauma.
Sioka C, Zikou A, Petrikis P, Asimakopoulos A, Alexiou G, Ragos V. Sioka C, et al. Among authors: ragos v. Mol Imaging Radionucl Ther. 2023 Jun 20;32(2):162-164. doi: 10.4274/mirt.galenos.2022.90958. Mol Imaging Radionucl Ther. 2023. PMID: 37337872 Free PMC article.
Anti-EGFR/BRAF-Tyrosine Kinase Inhibitors in Thyroid Carcinoma.
Papanikolaou V, Kyrodimos E, Mastronikolis N, Asimakopoulos AD, Papanastasiou G, Tsiambas E, Spyropoulou D, Katsinis S, Manoli A, Papouliakos S, Pantos P, Ragos V, Peschos D, Chrysovergis A. Papanikolaou V, et al. Among authors: ragos v. Cancer Diagn Progn. 2023 Mar 3;3(2):151-156. doi: 10.21873/cdp.10194. eCollection 2023 Mar-Apr. Cancer Diagn Progn. 2023. PMID: 36875315 Free PMC article. Review.
The Landscape of Single Nucleotide Polymorphisms in Papillary Thyroid Carcinoma.
Kyrodimos E, Chrysovergis A, Mastronikolis N, Papanastasiou G, Tsiambas E, Spyropoulou D, Katsinis S, Manoli A, Papouliakos S, Pantos P, Ragos V, Peschos D, Papanikolaou V. Kyrodimos E, et al. Among authors: ragos v. Cancer Diagn Progn. 2023 Jan 3;3(1):26-30. doi: 10.21873/cdp.10175. eCollection 2023 Jan-Feb. Cancer Diagn Progn. 2023. PMID: 36632585 Free PMC article. Review.
116 results